Upregulation of PD-1 in systemic CD4 + T cells promoted pulmonary fibrosis [11], while PD-L1 activation in fibroblasts of patients with IPF promoted invasion in vitro and lung fibrosis in vivo [12]. The gene discussed is CD4; the disease is pulmonary fibrosis.